HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
about
CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected IndividualsAdvances in HIV microbicide developmentSoluble factors from T cells inhibiting X4 strains of HIV are a mixture of β chemokines and RNases.Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: a cross-sectional study.Clearance of HIV type 1 envelope recombinant sendai virus depends on CD4+ T cells and interferon-gamma but not B cells, CD8+ T cells, or perforin.Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.Measuring glutathione redox potential of HIV-1-infected macrophages.Stromal cell-derived factor 1 polymorphism in patients infected with HIV and implications for AIDS progression in Tunisia.Control of HIV-1 infection by soluble factors of the immune response.Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques.Changes in B-Cell Counts and Percentages during Primary HIV Infection Associated with Disease Progression in HIV-Infected Men Who Have Sex with Men: A Preliminary StudyBroadly neutralizing antibodies developed by an HIV-positive elite neutralizer exact a replication fitness cost on the contemporaneous virusBeyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells.Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands.CD4+ T cell targeting of human immunodeficiency virus type 1 (HIV-1) peptide sequences present in vivo during chronic, progressive HIV-1 disease.Soluble HIV-1 envelope immunogens derived from an elite neutralizer elicit cross-reactive V1V2 antibodies and low potency neutralizing antibodiesIdentification of miRNA-mRNA crosstalk in CD4+ T cells during HIV-1 infection by integrating transcriptome analyses.Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug usersEffector and regulatory roles for B cells in HIV infection?Influence of common mucosal co-factors on HIV infection in the female genital tract.Antigen stimulation induces HIV envelope gp120-specific CD4(+) T cells to secrete CCR5 ligands and suppress HIV infection.In vitro restoration of Th17 response during HIV infection with an antiretroviral drug and Th17 differentiation cytokines.Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approach.Clonal CD4+ T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation.
P2860
Q19028101-A477C63F-8617-458A-B800-F940094F5090Q26852858-8F172226-482D-4C20-A79C-E3C5C60A9F9EQ30427403-D6F481AE-BFD7-4433-901F-A15733051D39Q33378492-31C4993D-EA5D-45BA-9564-2D2E3491EA68Q33827798-2AFA5A43-9D4C-440B-A455-55B375DC34FDQ34036250-8669D70A-CD7B-4EE2-9882-65BC1ECF8580Q34100215-E99A62B7-A115-428D-AF7D-9EF9E8EA5E96Q34339797-6ECF6F2D-214A-46A2-ACE5-224C87CF5A56Q34958392-4D6F6F5F-19AD-4169-AE87-D781456AF780Q35557274-DA28E07D-B245-4F67-A087-844B82CC118EQ35752416-2E36BF21-98B2-4F25-A7F3-10B15ABDBEDBQ35836048-36098868-FA1A-47A0-8FC2-C9ED339ED47AQ36075696-9646D78D-A0E0-488B-84F6-AA2E9C4CDCBCQ36397394-E5B0F6C9-AFF8-4968-9D5A-34470E63D71DQ36684398-96628541-8BC9-4CA4-9F44-97E7DF4E1563Q37252952-C5AA4A94-1D75-4FF9-B55B-820454A9B91BQ37327826-F42E7AB0-4557-47AA-896D-5453643940A3Q37510603-5BBFE185-769E-4412-9B2B-34CA35802E84Q37655340-3B19C444-A9C0-4813-BFAB-FEC4CE01513DQ37725740-2ADA0559-47D6-4407-BECF-6DAEE38C7861Q37997855-FB71525D-AF93-40AE-ADA7-5B73262C2DE9Q38195075-871A3AB0-C7B8-41FE-83C9-2BE20E16B7F9Q39124318-2BA5716F-345D-4AFE-B2B8-10C097FEFD0DQ42007018-C531F5CD-F864-4A11-901D-2CAA6460FB0FQ46477869-8B66C718-43AE-4DB3-93ED-D5509578059BQ52568482-676ACFA5-8FEA-4A9F-A1B2-1754AFF44EE2
P2860
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
@ast
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
@en
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
@nl
type
label
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
@ast
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
@en
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
@nl
prefLabel
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
@ast
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
@en
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
@nl
P2093
P2860
P356
P1476
HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.
@en
P2093
Anthony DeVico
Fiorenza Cocchi
George K Lewis
Kenneth C Bagley
Roberta Kamin-Lewis
Sayed F Abdelwahab
P2860
P304
15006-15010
P356
10.1073/PNAS.2035075100
P407
P50
P577
2003-12-01T00:00:00Z